Skip to main content

Animations

MJFF Publications

3781 - 3790 of 9038 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2019
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-03185-z
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-021-00441-8
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz296
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01140-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms22052689
    Citation Count: 29
  • Summary Details
    OPEN
    Title: BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2021.03.026
    Citation Count: 233
  • Summary Details
    OPEN
    Title: Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2021.633655
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.2020858118
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2005894118
    Citation Count: 92
  • Summary Details
    OPEN
    Title: Implementation and Patient Experience of Outpatient Teleneurology
    Journal Name: Telemedicine and e-Health
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1089/tmj.2020.0032
    Citation Count: 30
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.